Search research articles
Contact Us
Filters
Showing results (231-240 of 703) with videos related to
Page
of 71
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 2022
Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events
Christopher A Muir, Cameron C G Wood, Roderick J Clifton-Bligh, et al.
Journal for Immunotherapy of Cancer
|
June 8, 2025
Hyperglycemia in patients treated with immune checkpoint inhibitors: key clinical challenges and multidisciplinary consensus recommendations
Linda Wu, Venessa Tsang, Roderick Clifton-Bligh, et al.
The Lancet. Oncology
|
November 20, 2016
Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
Georgina V Long, Jean-Jacques Grob, Paul Nathan, et al.
Molecular Oncology
|
January 31, 2014
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
Matteo S Carlino, Jason R Todd, Kavitha Gowrishankar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 15, 2018
Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
G V Long, S S Tykodi, J G Schneider, et al.
Pigment Cell & Melanoma Research
|
April 5, 2013
Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California
R S Lo, A Ribas, G V Long, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2025
Predictive performance of the clinicopathologic gene expression profile (CP-GEP) in identifying cutaneous melanoma patients for whom sentinel lymph node biopsy is unnecessary: A systematic review and meta-analysis
Terence Wong, Sydney Ch'ng, Peter Ferguson, et al.
Molecular Cancer Therapeutics
|
September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine
James S Wilmott, Varsha Tembe, Julie R Howle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2020
Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia
Angela M Hong, Cora Waldstein, Brindha Shivalingam, et al.
JAMA Oncology
|
February 10, 2018
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies
Jenny H Lee, Georgina V Long, Alexander M Menzies, et al.
Page
of 71
Search research articles
Search
Showing results (231-240 of 703) with videos related to
Sort By:
Page
of 71
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 2022
Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events
Christopher A Muir, Cameron C G Wood, Roderick J Clifton-Bligh, et al.
Journal for Immunotherapy of Cancer
|
June 8, 2025
Hyperglycemia in patients treated with immune checkpoint inhibitors: key clinical challenges and multidisciplinary consensus recommendations
Linda Wu, Venessa Tsang, Roderick Clifton-Bligh, et al.
The Lancet. Oncology
|
November 20, 2016
Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
Georgina V Long, Jean-Jacques Grob, Paul Nathan, et al.
Molecular Oncology
|
January 31, 2014
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
Matteo S Carlino, Jason R Todd, Kavitha Gowrishankar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 15, 2018
Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
G V Long, S S Tykodi, J G Schneider, et al.
Pigment Cell & Melanoma Research
|
April 5, 2013
Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California
R S Lo, A Ribas, G V Long, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2025
Predictive performance of the clinicopathologic gene expression profile (CP-GEP) in identifying cutaneous melanoma patients for whom sentinel lymph node biopsy is unnecessary: A systematic review and meta-analysis
Terence Wong, Sydney Ch'ng, Peter Ferguson, et al.
Molecular Cancer Therapeutics
|
September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine
James S Wilmott, Varsha Tembe, Julie R Howle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2020
Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia
Angela M Hong, Cora Waldstein, Brindha Shivalingam, et al.
JAMA Oncology
|
February 10, 2018
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies
Jenny H Lee, Georgina V Long, Alexander M Menzies, et al.
Page
of 71